UBC Medical Indonesia Tbk.

Jakarta Stock Exchange:LABS.JK

Sector

🏥 Health Care

Industries

💻 Telehealth

🧬 Biotechnology

💊 Drugstores & Retail Pharmacies

🩺 Medical Instruments

Location

Indonesia

Market Cap

USD 33.55 M

Share Price

USD 0.01

Avg Daily Volume

1,042,736

Change (1 day)

-0.58%

Change (1 year)

Change (YTD)

16.94%

UBC Medical Indonesia Tbk. EBITDA Margin for the year ending December 31, 2024: 14.87%

UBC Medical Indonesia Tbk. EBITDA Margin is 14.87% for the year ending December 31, 2024, a 13.32% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

UBC Medical Indonesia Tbk. EBITDA Margin for the year ending December 31, 2023 was 13.13%, a -17.66% change year over year.
UBC Medical Indonesia Tbk. EBITDA Margin for the year ending December 31, 2022 was 15.94%, a 95.20% change year over year.
UBC Medical Indonesia Tbk. EBITDA Margin for the year ending December 31, 2021 was 8.17%.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	EBITDA Margin	Net Income Margin	EBT Margin	Operating Income Margin

Jakarta Stock Exchange: LABS.JK

UBC Medical Indonesia Tbk.

CEO	Mr. Franciscus Xaverius Yoshua Raintjung
IPO Date	July 10, 2024
Location	Indonesia
Headquarters	Etana Building
Employees	62
Sector	🏥 Health Care
Industries Telehealth 🧬 Biotechnology 💊 Drugstores & Retail Pharmacies 🩺 Medical Instruments

Description

PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. PT UBC Medical Indonesia Tbk was founded in 2014 and is based in Jakarta Timur, Jakarta. PT UBC Medical Indonesia Tbk operates as a subsidiary of PT Optel Investama Mulia.